BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36285482)

  • 1. Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation.
    Komatsuda H; Wakisaka R; Kono M; Kumai T; Hayashi R; Yamaki H; Sato R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Takahara M; Katada A; Kobayashi H
    Cancer Sci; 2023 Feb; 114(2):399-409. PubMed ID: 36285482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
    Kono M; Komatsuda H; Yamaki H; Kumai T; Hayashi R; Wakisaka R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Kishibe K; Takahara M; Katada A; Hayashi T; Kobayashi H; Harabuchi Y
    Oncoimmunology; 2022; 11(1):2021619. PubMed ID: 35003900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
    Kumai T; Matsuda Y; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Celis E; Kobayashi H
    Br J Cancer; 2013 Oct; 109(8):2155-66. PubMed ID: 24045666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
    Hayashi R; Nagato T; Kumai T; Ohara K; Ohara M; Ohkuri T; Hirata-Nozaki Y; Harabuchi S; Kosaka A; Nagata M; Yajima Y; Yasuda S; Oikawa K; Kono M; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Harabuchi Y; Kobayashi H
    Oncoimmunology; 2020 Dec; 10(1):1856545. PubMed ID: 33457076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.
    Mimura K; Kua LF; Shiraishi K; Kee Siang L; Shabbir A; Komachi M; Suzuki Y; Nakano T; Yong WP; So J; Kono K
    Cancer Sci; 2014 Oct; 105(10):1236-44. PubMed ID: 25154680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
    Kono M; Kumai T; Hayashi R; Yamaki H; Komatsuda H; Wakisaka R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Kobayashi H; Harabuchi Y
    Cancer Immunol Immunother; 2021 Dec; 70(12):3421-3434. PubMed ID: 33866408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
    Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
    Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.
    Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S
    Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
    Frøsig TM
    Dan Med J; 2015 Aug; 62(8):B5144. PubMed ID: 26239596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.
    Kumai T; Matsuda Y; Ohkuri T; Oikawa K; Ishibashi K; Aoki N; Kimura S; Harabuchi Y; Celis E; Kobayashi H
    Oncoimmunology; 2015 Feb; 4(2):e976077. PubMed ID: 25949874
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
    Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
    Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
    Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis.
    De Souza Setubal Destro MF; Bitu CC; Zecchin KG; Graner E; Lopes MA; Kowalski LP; Coletta RD
    Int J Oncol; 2010 Jan; 36(1):141-9. PubMed ID: 19956843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.